MiNK Therapeutics INKT Earnings Call Transcripts

NASDAQ INKT
$10.22 +0.21 (+2.14%)
As of: Nov 11, 2026 · 3:53 PM EST
5 earnings calls on file for MiNK Therapeutics, from Q2 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

MiNK Therapeutics Q2 2026 Earnings Call

Aug 13, 2026 4,522 words · 20 min read
  • Stefanie Perna-NacarInvestor Relations
  • Jennifer BuellPresident and Chief Executive Officer
  • Terese HammondHead of Development
  • Melissa OrilallPrincipal Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

MiNK Therapeutics Earnings Call Transcripts

Calls5
LatestAug 13, 2026
SinceQ2 2025

Fiscal 2026

Fiscal 2025

All 5 MiNK Therapeutics transcripts Register to get access to MiNK Therapeutics’s earnings call transcripts.